Securities fraud litigation history and active cases
In Litigation
1
Settlement
1
Closed
0
Total Settlement
$17M
25-1036 • December 10, 2021
Class Period Start
November 25, 2019
Class Period End
October 15, 2021
PSLRA Deadline
February 8, 2022
Case Allegations
10b5
Statutes of Repose
Nov 25, 2022
Country
United States
Court
Federal Court
Feb 19, 2025
Jan 17, 2025
The court has granted the defendants' request to dismiss the lawsuit. Depending on the court's decision, the plaintiffs may be allowed to file an updated complaint or pursue an appeal.
May 28, 2024
After reviewing the complaint(s) filed by plaintiffs, defendants have filed a motion requesting that the court dismiss some or all of the plaintiffs' claims. In a motion to dismiss, defendants might challenge the validity of plaintiffs' claims or adequacy of plaintiffs' pleadings. Once a motion to dismiss is filed, the judge will make a decision on whether part or all of the case should be dismissed or the case can proceed as alleged.
May 1, 2024
A new complaint has been filed on behalf of certain investors in Revance Therapeutics, Inc.. Amended complaints may contain additional facts, parties, allegations, a change in the class definition, etc.
Apr 2, 2024
The court has granted the defendants' request to dismiss the lawsuit. Depending on the court's decision, the plaintiffs may be allowed to file an updated complaint or pursue an appeal.
3:25cv18 • January 3, 2025
Class Period Start
February 29, 2024
Class Period End
February 28, 2025
PSLRA Deadline
March 4, 2025
Case Allegations
10b5
Statutes of Repose
Mar 1, 2027
Country
United States
Court
Federal Court
Please note that for cases in the settlement stage, claims are handled by the claims administrator and NOT Levi & Korsinsky. Any information or documentation previously provided to us does not constitute submission of a claim. If you need to file a claim, check the status of a claim, or have questions regarding distribution of settlement funds, please contact the claims administrator below.
Claim Deadline
August 28, 2026
Settlement Fund
$17,000,000
Settlement Status
Final Approval
Settlement Class
All persons or entities that purchased or acquired Revance Securities (defined below) during the period of February 29, 2024 through the close of the subject Merger on February 6, 2025, inclusive (the “Class Period”), including common stock (CUSIP: 761330109; ticker “RVNC”) and 1.75% fixed coupon Convertible Senior Unsecured Notes (CUSIP: 761330AB5).
Claim Administrator
A.B. Data, Ltd.
P.O. Box 173120
Milwaukee, WI 53217
+1 877-507-1390
[email protected]
Settlement Website
https://revancesecuritiessettlement.com/home/Hearing Date
August 10, 2026
Opt-out Deadline
July 13, 2026
Settlement Note
Download hereProof Of Claim
Download here
Aug 11, 2026
Final Approval of Settlement
The court has granted final approval of the settlement. Eligible investors who submit valid claims may receive a payment once the claims review and distribution process is completed.
Jun 29, 2026
Motion for Final Approval of Settlement
The parties have asked the court to grant final approval of the proposed settlement. The judge will consider whether the settlement should be approved after reviewing the settlement terms and any objections. If approved, eligible investors who submit valid claims may receive a payment after the claims review and distribution process is completed.
Apr 30, 2026
Notice of Pendency
Apr 30, 2026
Proof of Claim Form
To receive your portion of the recovery (if you are eligible), you must submit this form to the claims administrator by the deadline indicated on the form itself. If you do not submit this form in time, you will not be entitled to compensation. If you have questions about how to complete the form, you should contact the claims administrator.
Apr 10, 2026
Preliminary Approval of Settlement
The court has granted preliminary approval of a proposed settlement. This means the settlement can move forward for further consideration, but it has not yet received final approval. Potential class members will generally receive notice explaining the settlement, their rights, and any deadlines for submitting a claim, objecting to the settlement, or choosing not to participate.
TOP
